APA (7th ed.) Citation

YC, H., WC, K., HY, S., SH, C., SH, H., CJ, Y., . . . CC, H. (2026). Efficacy of same-day initiation of antiretroviral therapy with coformulated bictegravir, emtricitabine, and tenofovir alafenamide: Week 48 results of a single-arm, open-label, multicenter clinical trial. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 163, 108284. https://doi.org/10.1016/j.ijid.2025.108284

Chicago Style (17th ed.) Citation

YC, Huang, et al. "Efficacy of Same-day Initiation of Antiretroviral Therapy with Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide: Week 48 Results of a Single-arm, Open-label, Multicenter Clinical Trial." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 163 (2026): 108284. https://doi.org/10.1016/j.ijid.2025.108284.

MLA (9th ed.) Citation

YC, Huang, et al. "Efficacy of Same-day Initiation of Antiretroviral Therapy with Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide: Week 48 Results of a Single-arm, Open-label, Multicenter Clinical Trial." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, vol. 163, 2026, p. 108284, https://doi.org/10.1016/j.ijid.2025.108284.